Daniel Lyons, PhD

Equity Research Analyst
Janus Capital Group

Daniel Lyons is an equity research analyst at Janus Capital Group focusing on the biotechnology, diagnostics and life science tool industries. Dr. Lyons started consulting for Janus in February 1997 and joined the health care team full time in September 2000.

He received his bachelor of arts degree in biochemistry and chemistry, graduating magna cum laude, from Rice University. Dr. Lyons also earned a Ph.D. from Stanford University’s Program in Immunology and conducted postdoctoral research with a Nobel laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 16 years of financial industry experience.

Following his research in immunology he had a strong interest in children’s health advancement through vaccination.

Favorite Movie/Book: At the Light We Cannot See, Walter Mitty

Personal Hero: Tom Cech

Hometown Fun Fact: Los Alamos, NM - We glow in the dark!

Favorite Thing To Do in Colorado: Mountain Biking

Why Vaccinate: Vaccination is important to keep our children and public safe and healthy.